Institut für Frauengesundheit GmbH
Industry / private company
Location:
Erlangen,
Germany (DE)
ISNI: -
ROR: https://ror.org/01f30wv40
Show on Map:
Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer – A single-arm phase II trial (NeoImmunoboost, AGO-B-041) (2023)
Fasching P, Hein A, Kolberg HC, Häberle L, Uhrig S, Rübner M, Belleville E, et al.
Journal article
Patterns and Trends of Herbal Medicine Use among Patients with Gynecologic Cancer (2021)
Theuser AK, Hack C, Fasching P, Antoniadis S, Grasruck K, Wasner S, Knoll S, et al.
Journal article
Gynecologists’ attitudes toward and use of complementary and integrative medicine approaches: results of a national survey in Germany (2020)
Grimm D, Voiss P, Paepke D, Dietmaier J, Cramer H, Kümmel S, Beckmann M, et al.
Journal article
Treatment of severe traumatic brain injury in German pediatric intensive care units—a survey of current practice (2019)
Regensburger A, Konrad V, Trollmann R, Eyüpoglu IY, Huebner H, Zierk J, Voelkl TMK, Fahlbusch FB
Journal article
Detyrosinated tubulin is decreased in fetal vessels of preeclampsia placentas (2018)
Huebner H, Knoerr B, Betzler A, Kehl S, Baier F, Wachter DL, Strick R, et al.
Journal article